间歇性肺病特定生物标志物的诊断性能:一个单一中心研究
Anu S Maharjan1,2, Sogol S Amjadi3, Troy D Jaskowski2
1Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Clinical chemistry and laboratory medicine
|November 28, 2024
概括
克雷布斯登肺-6 (KL-6) 和表面活性蛋白D (SP-D) 在间歇性肺病 (ILD) 中显示高水平,有助于诊断和风险分层. 这些生物标志物对于有效管理ILD患者至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 生物标志物发现发现
- 结合组织疾病 结合组织疾病
背景情况:
- 间歇性肺病 (ILD) 的诊断和管理需要可靠的生物标志物.
- 连接组织疾病相关的ILD (CTD-ILD) 存在诊断方面的挑战.
- 克雷布斯·登·隆根-6 (KL-6),表面活性蛋白A (SP-A) 和表面活性蛋白D (SP-D) 是潜在的ILD生物标志物.
研究的目的:
- 评估KL-6,SP-A和SP-D在ILD中的临床意义.
- 评估这些生物标志物的有用性,以诊断ILD和区分严重程度.
- 确定它们在治疗CTD-ILD患者中的作用.
主要方法:
- 对KL-6,SP-A和SP-D的血清水平测量了122名怀疑有CTD-ILD的患者和120名健康对照.
- 患者被追溯分为ILD或非ILD,并进一步分为CTD-ILD或其他ILD类别.
- 使用高分辨率计算机断层扫描 (HRCT) 来评估ILD的严重程度 (中度与严重).
主要成果:
- 与非ILD对照组相比,ILD患者的SP-A (p<0.02),KL-6和SP-D (p<0.0001) 水平显著升高.
- 所有生物标志物都表现出高特异性 (89-93%),对KL-6的敏感度为75%,SP-D的敏感度为77%,SP-A的敏感度为17%.
- 结合KL-6和SP-D提供了与使用所有生物标志物的诊断准确性相比,在严重的ILD中水平更高.
结论:
- 升高的KL-6和SP-D水平是ILD患者的显著指标.
- 这些生物标志物是用于ILD诊断和风险分层的宝贵工具.
- 在间歇性肺病的临床管理中,KL-6和SP-D的帮助.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
382
相关概念视频
01:26Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:30Pneumonia III: Complications and Assessment
168
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
168